3Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006,16 : 109-142.
4Polyzos SA, Kita M, Efstathiadou Z, et al. Serum thyrotrepin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Onco1,2008 ,134 :953-960.
5Josefson J, Zimmerman D. Thyroid nodules and cancers in children. Pediatr Endocrinol Rev, 2008,6 : 14-23.
6Sundram F, Robinson B G, Kung A, et al. Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: a report and clinical practice guideline. Thyroid, 2006, 16 : 461- 469.
7Frates MC, Benson CB, Charbonean JW, et al. Management of thyroid nodules detected at US: society of radiologists in ultrasound conference statement. Radiology, 2005, 237 : 794- 800.
8Moon W, Jung SL, Lee JH, et al. Benign and malignant thyroid nodules : US differentiation-Multicenter retrospective study. Radiology, 2008,247 : 762 -770.
9Bastin S, Bolland M J, Crexson MS. Role of ultrasound in the assessment of nodular thyroid disease. J Med Imaging Radiat Oncol, 2009,53 : 177-187.
10Das DK, Mallik MK, Haji BE, et al. Psammoma body and its precursors in papillary thyroid carcinoma: a study by fine-needle aspiration cytology. Diagu Cytopathol, 2004,31:380-386.
